All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Support of Profesional Development

Public support

  • Provider

    Ministry of Education, Youth and Sports

  • Programme

  • Call for proposals

  • Main participants

    Fyziologický ústav AV ČR, v. v. i.

  • Contest type

    OP - EU Operational Programme

  • Contract ID

    17_050/0008021 - 01

Alternative language

  • Project name in Czech

    Podpora profesního růstu

  • Annotation in Czech

    Hlavním cílem projektu je podpora profesního růstu (zvýšení konkurenceschopnosti na trhu práce) pomocí dlouhodobých zahraničních stáží ve významných evropských laboratořích.Mezinárodní spolupráce přinese členům týmu rozvoj stávajících vědeckých znalostí a dovedností, dále osvojení nových technik a výzkumných metod a prohloubení mezinárodní spolupráce. K prezentaci výsledků a navázání nových kontaktů v rámci Evropského výzkumného prostoru budou sloužit účasti na zahraničních konferencích.

Scientific branches

  • R&D category

    ZV - Basic research

  • CEP classification - main branch

    FP - Other medical fields

  • CEP - secondary branch

    FI - Traumatology and orthopaedics

  • CEP - another secondary branch

    FH - Neurology, neuro-surgery, nuero-sciences

  • OECD FORD - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    30103 - Neurosciences (including psychophysiology)<br>30106 - Anatomy and morphology (plant science to be 1.6)<br>30107 - Medicinal chemistry<br>30108 - Toxicology<br>30109 - Pathology<br>30210 - Clinical neurology<br>30211 - Orthopaedics<br>30221 - Critical care medicine and Emergency medicine<br>30223 - Anaesthesiology<br>30224 - Radiology, nuclear medicine and medical imaging<br>30225 - Allergy<br>30226 - Rheumatology<br>30227 - Geriatrics and gerontology<br>30229 - Integrative and complementary medicine (alternative practice systems)<br>30230 - Other clinical medicine subjects<br>30307 - Nursing<br>30308 - Nutrition, Dietetics<br>30309 - Tropical medicine<br>30310 - Parasitology<br>30311 - Medical ethics<br>30312 - Substance abuse<br>30501 - Forensic science<br>30502 - Other medical science

Completed project evaluation

  • Provider evaluation

    U - Uspěl podle zadání (s publikovanými či patentovanými výsledky atd.)

  • Project results evaluation

    The mobility participant worked in a laboratory at the Wolfson Center for Age-Related Diseases in London. From a scientific point of view, a number of findings have been made. Research has shown some relationships between metalloproteases ADAM10 and ADAM17, FKN solubilization, and the resulting allodynia. Behavioral experiments using an ADAM17 inhibitor showed a relationship between FKN in cerebrospinal fluid and a decrease in mechanical allodynia. The findings were summarized in: The Role of Spinal Cord CX3CL1 / CX3CR1 Signaling in Chronic Pain https://link.springer.com/article/10.1007/s43152‐020‐00006‐9 and also Contribution of ADAM10 And ADAM17 to Fractalkine shedding and neuron ‐ microglia communication in neuropathic pain (under review). A significant benefit is also the ongoing cooperation between laboratories and the application of acquired techniques. Participation in conferences during the internship was also very beneficial.

Solution timeline

  • Realization period - beginning

    Dec 1, 2017

  • Realization period - end

    Jul 31, 2020

  • Project status

    U - Finished project

  • Latest support payment

    Feb 26, 2020

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP21-MSM-EF-U/01:1

  • Data delivery date

    Jun 25, 2021

Finance

  • Total approved costs

    6,908 thou. CZK

  • Public financial support

    6,908 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    360 thou. CZK